Royalty Pharma: Key Strategic Updates To Be Priced In

Following our Strong Buy suggestion in early November 2024, Royalty Pharma plc (NASDAQ: RPRX ) stock price increased by more than 16%, with a clear outperformance over the S&P 500 change (Fig 1). As a reminder, our buy rating was supportedBuy-side hedge professionals conducting fundamental, income oriented, long term analysis across sectors globally in developed markets. Please shoot us a message or leave a comment to discuss ideas.DISCLOSURE: All of our articles are a matter of opinion, informed as they mi ...